# Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer

> **NCT07124858** · NA · NOT_YET_RECRUITING · sponsor: **Federation Francophone de Cancerologie Digestive** · enrollment: 300 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer (CRC)
- Antineoplastic Agents, Immunological
- VEGFR-TKI

## Interventions

- **DRUG:** Fruquintinib

## Key facts

- **NCT ID:** NCT07124858
- **Lead sponsor:** Federation Francophone de Cancerologie Digestive
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2031-03-01
- **Final completion:** 2031-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07124858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07124858, "Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07124858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*